The global type 2 diabetes mellitus treatment market is expected to expand at a CAGR of 8.0% during the forecast period. The large prevalence of diabetes is the major driver of the market. According to the Centers for Disease Control Prevention (CDC), close to 30.3 million people in the U.S. were diagnosed with diabetes in 2015. Increasing cases of obesity, overnment funding, and establishment of regulations can dr ive the market demand till the end of the forecast period. The outbreak of the COVID-19 virus has put diabetics at higher risk of contracting the disease. According to a survey in the U.K., out of 23,804 patients dying from the virus, nearly 32% had type 2 diabetes.